SCHEMBL9075358

SCHEMBL9075358

Cc1c(Cc2ccccc2Cl)cccc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.55
MAPT P10636 4/20 0.52
MAPK1 P28482 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 7/20 0.52
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
TSHR P16473 3/20 0.50
NPC1 O15118 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.49
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HSD17B10 Q99714 1/20 0.44
HPGD P15428 3/20 0.44
POLB P06746 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27645574 0.80 ALDH1A1 (0.70) TDP1MAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL9076056 0.80 TDP1 (0.53) TDP1MAPTL3MBTL1ALDH1A1PKM
SCHEMBL700473 0.79 TDP1 (0.72) TDP1MAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL31148308 0.79 TDP1 (0.72) TDP1MAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL961310 0.78 TSHR (0.67) TDP1MAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL14641737 0.78 TDP1 (0.69) TDP1MAPTMAPK1L3MBTL1ALDH1A1
Methyl Alcohol SCHEMBL27492265 0.76 TDP1 (0.67) TDP1MAPTL3MBTL1ALDH1A1PKM
SCHEMBL3849609 0.76 TDP1 (0.60) TDP1MAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL10650196 0.75 TDP1 (0.55) TDP1MAPTL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL715298 0.75 TDP1 (0.64) TDP1MAPTMAPK1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5506234-A PSYCHOPHARMACEUTICAL AGENTS WHICH BIND TO BENZODIAZEPINE RECEPTORS; ANXIOLYTIC AGENTS; MINIMAL SIDE EFFECTS SCHERING AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0557497-A1 NEW $g(b)-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-09-01 EP disclosed
WO-1993006100-A1 NEW β-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-01 WO disclosed